InflaRx NV (IFRX) Begins Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe – StreetInsider.com

InflaRx NV (IFRX) Begins Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe – StreetInsider.com

InflaRx NV (IFRX) Begins Second Phase II Clinical Trial of IFX-1 in ANCA-Associated Vasculitis with First Patient Treated in Europe – StreetInsider.com
Published on 2019-05-14